FrancophonIA/ELRC3.0 huggingface dataset:
English: See section 2 “TRISENOX contains sodium”.
Croatian: Pogledajte dio 2 „TRISENOX sadrži natrij“.
English: If you experience discomfort or if you feel unwell after a TRISENOX injection, you should wait until the symptoms go away before driving or using machines.
Croatian: Ako osjetite nelagodu ili Vam nije dobro nakon injekcije TRISENOXA, morate pričekati da se simptomi povuku prije nego što počnete voziti ili upravljati strojevima.
English: Approximately 15 % of the administered TRISENOX dose is excreted in the urine as unchanged AsIII.
Croatian: Približno 15% primijenjene doze TRISENOXA izlučuje se u mokraći kao nepromijenjeni AsIII.
English: The key efficacy results are summarised in table 3 below:
Croatian: Ključni rezultati djelotvornosti sažeti su u tablici 3 u nastavku
English: - Blood tests (potassium, calcium, magnesium and liver function) should be repeated during your treatment with TRISENOX.
Croatian: - Krvne pretrage (kalij, kalcij, magnezij i funkcija jetre) moraju se ponoviti tijekom liječenja TRISENOXOM.
English: 2-Year cumulative incidence of relapse (CIR)
Croatian: 2-godišnja kumulativna incidencija relapsa (engl. cumulative incidence of relapse CIR)
English: In particular tell your doctor - if you are taking any of various types of medicines which could cause a change in the rhythm of your heartbeat.
Croatian: Naročito obavijestite svog liječnika - ako uzimate bilo koje druge lijekove koji su mogli uzrokovati promjenu Vašeg srčanog ritma.
English: TRISENOX may cause harm to the foetus when used by pregnant women.
Croatian: TRISENOX može oštetiti plod ako ga koriste trudne žene.
English: TRISENOX with food and drink There are no restrictions on your food or drink while you are receiving TRISENOX.
Croatian: TRISENOX s hranom i pićem Nema ograničenja za uzimanje hrane i pića dok ste na terapiji TRISENOXOM.
English: Medicinal products that are used to lower the white blood cell count often exacerbate the toxicities associated with leucocytosis, and no standard approach has proven effective.
Croatian: Lijekovi koji se koriste za snižavanje leukocita često pojačaju toksičnosti povezane s leukocitozom, te se nijedan standardni pristup nije pokazao učinkovitim.
English: Pharmacotherapeutic group: Other antineoplastic agents, ATC code: L01XX27
Croatian: Farmakoterapijska skupina: Drugi antineoplastici, ATK oznaka: L01XX27 Mehanizam djelovanja
English: Twenty-seven patients had leucocytosis (WBC  10 x 103/l) during induction, 4 of whom had values above 100,000/l.
Croatian: Dvadeset i sedam bolesnika je imalo leukocitozu (leukociti ≥ 10 x 103/µl) tijekom indukcije, a od njih su 4 imala vrijednosti iznad 100 000/µl.
English: Systemic exposure to MMAV and DMAV tended to be larger in patients with renal impairment; the clinical consequence of this is unknown but no increased toxicity was noted.
Croatian: Sistemska izloženost MMAV i DMAV veća je kod bolesnika s oštećenjem bubrega; kliničke posljedice ovog nisu poznate, ali nije primijećena povećana toksičnost.
English: The majority of patients do not require permanent termination of TRISENOX therapy during treatment of the APL differentiation syndrome.
Croatian: Većina bolesnika ne zahtijeva trajan prekid liječenja TRISENOXOM tijekom liječenja sindroma diferencijacije APL-a.
English: Patients with complete remission received consolidation therapy with TRISENOX for 25 additional doses over a 5 week period.
Croatian: Bolesnici s potpunom remisijom primili su konsolidacijsku terapiju TRISENOXOM od 25 dodatnih doza u razdoblju od 5 tjedana.
English: • any medicines that cause a decrease in magnesium or potassium in your blood (e.g. amphotericin B)
Croatian: • bilo koje lijekove koji uzrokuju smanjenje magnezija ili kalija u krvi (primjerice, amfotericin B)
English: If your disease responds to TRISENOX, you will be given 4 additional treatment cycles.
Croatian: Ako Vaša bolest reagira na liječenje TRISENOXOM, započet ćete 4 dodatna ciklusa liječenja.
English: The methylated metabolites of AsIII (MMAV, DMAV) are primarily excreted in the urine.
Croatian: Metilirani metaboliti AsIII (MMAV, DMAV) izlučuju se primarno u mokraći.
English: TRISENOX is for single use only and any unused portions of each ampoule or of each vial must be discarded properly.
Croatian: TRISENOX je samo za jednokratnu uporabu i neiskorišteni dio svake ampule ili svake bočice mora se odložiti na ispravan način.
English: Haematological and gastrointestinal toxicity
Croatian: Hematološka i gastrointestinalna toksičnost
English: No data are available on patient with variant translocations like t(11;17) (PLZF/RARα).
Croatian: Nema dostupnih podataka o bolesniku s drugačijim translokacijama poput t(11;17) (PLZF/RARα).
English: Opening the ampoule: Hold the ampoule of TRISENOX with the coloured point upwards and in front of you.
Croatian: Otvaranje ampule: Držite ampulu TRISENOXA s obojenim vrhom usmjerenim nagore te ispred Vas.
English: One was a single investigator clinical study (n=12) and the other was a multicentre, 9-institution study (n=40).
Croatian: Jedno je ispitivanje bilo s jednim ispitivačem (n = 12), a drugo je bilo multicentrično s 9 uključenih centara (n = 40).
English: The duration of treatment with penicillamine must be evaluated taking into account the urinary arsenic laboratory values.
Croatian: Trajanje liječenja penicilaminom mora se procijeniti uzimajući u obzir vrijednosti laboratorijskih pretraga arsena u mokraći.
English: If the toxic event does not recur within 7 days of restarting treatment at the reduced dose, the daily dose can be escalated back to 100 % of the original dose.
Croatian: Ako se toksični događaj ne pojavi unutar 7 dana od ponovnog početka liječenja pri smanjenoj dozi, dnevna doza može se ponovno povećati na 100% početne doze.
English: Each cycle consists of 20 doses given 5 days per week (followed by 2 days interruption) for 4 weeks followed by 4 weeks interruption.
Croatian: Svaki ciklus sastoji se od 20 doza koje se daju 5 dana u tjednu (nakon čega slijedi 2 dana pauze) tijekom 4 tjedna nakon čega slijedi pauza od 4 tjedna.
English: Patients with acute promyelocytic leukaemia, whose disease has not responded to other therapies Your doctor will give you TRISENOX once every day as an infusion.
Croatian: Bolesnici s akutnom promijelocitnom leukemijom čija bolest ne reagira na druge terapije Liječnik će Vam svakog dana jedanput dnevno davati TRISENOX kao infuziju.
English: Conventional Cytogenetics [t(15;17)] Absent
Croatian: standardna citogenetika [t(15;17)]
English: Dose delay, modification and reinitiation
Croatian: Odgoda doze, izmjena i ponovni početak terapije
English: The results are summarised in the table 4 below.
Croatian: Rezultati su sažeti u tablici 4 u nastavku.
English: It is recommended that chemotherapy not be added to treatment with steroids since there is no experience with administration of both steroids and chemotherapy during treatment of the leukocyte activation syndrome due to TRISENOX.
Croatian: Preporučuje se da se kemoterapija ne dodaje liječenju steroidima jer nema iskustva s primjenom i steroida i kemoterapije tijekom liječenja sindroma aktivacije leukocita izazvanog TRISENOXOM.
English: Warnings and precautions You must talk to your doctor or nurse before you are given TRISENOX, if - you have impaired kidney function.
Croatian: Morate se obratiti svom liječniku ili medicinskoj sestri prije nego što primite TRISENOX, ako - imate oštećenu funkciju bubrega
English: Previous treatment with anthracyclines may increase the risk of QT prolongation.
Croatian: Prethodno liječenje antraciklinima može povećati rizik od produljenja QT intervala.
English: TRISENOX contains less than 1 mmol sodium (23 mg) per dose.
Croatian: TRISENOX sadrži manje od 1 mmol (23 mg) natrija po dozi.
English: In such cases, treatment must resume at 50 % of the preceding daily dose.
Croatian: U takvim se slučajevima liječenje mora nastaviti s 50% prethodne dnevne doze.
English: Men should also use effective contraception during treatment with TRISENOX.
Croatian: Muškarci također moraju koristiti učinkovitu kontracepciju tijekom liječenja TRISENOXOM.
English: Single Center Multicenter Study
Croatian: Pojedinačni centar Multicentrično ispitivanje
English: No formal assessments of pharmacokinetic interactions between TRISENOX and other therapeutic medicinal products have been conducted.
Croatian: Nisu provedena službena ispitivanja farmakokinetičkih interakcija između TRISENOXA i drugih lijekova.
English: After administration at 0.15 mg/kg on a daily (n=6) or twice-weekly (n=3) regimen, an approximate 2-fold accumulation of AsIII was observed as compared to a single infusion.
Croatian: Nakon primjene režima od 0,15 mg/kg dnevno (n = 6) ili dvaput tjedno (n = 3), približna dvostruka akumulacija AsIII primijećena je u usporedbi s pojedinačnom infuzijom.
English: 18-Month
Croatian: 18-mjesečni
English: Of 7 patients under 18 years of age (range 5 to 16 years) treated with TRISENOX at the recommended dose of 0.15 mg/kg/day, 5 patients achieved a complete response (see section 4.2).
Croatian: Od 7 bolesnika mlađih od 18 godina (raspon od 5 do 16 godina) koji su liječeni TRISENOXOM pri preporučenoj dozi od 0,15 mg/kg/dan, 5 bolesnika postiglo je potpuni odgovor (vidjeti dio 4.2).
English: Pharmacokinetic data from patients with hepatocellular carcinoma having mild to moderate hepatic impairment indicate that AsIII or AsV do not accumulate following twice-weekly infusions.
Croatian: Oštećenje jetre Farmakokinetički podaci za bolesnike s hepatocelularnim karcinomom koji imaju blago do umjereno oštećenje jetre pokazuju da se AsIII ili AsV ne akumulira nakon infuzije dva puta tjedno.
English: The decline from peak plasma concentration of AsIII occurs in a biphasic manner and is characterized by an initial rapid distribution phase followed by a slower terminal elimination phase.
Croatian: Pad vršne plazmatske koncentracije AsIII događa se na dvofazni način te ga karakterizira početna brza faza raspodjele nakon koje slijedi sporija završna faza eliminacije.
English: What TRISENOX is and what it is used for What you need to know before you are given TRISENOX How TRISENOX is given
Croatian: Što je TRISENOX i za što se koristi Što morate znati prije nego što primite TRISENOX
English: In these studies, leucocytosis was not treated with chemotherapeutic medicinal products.
Croatian: U ovim ispitivanjima, leukocitoza se nije liječila kemoterapeuticima.
English: There is limited clinical data on the use of TRISENOX in the elderly population.
Croatian: Dostupni su ograničeni podaci o primjeni TRISENOXA u starije populacije.
English: Post-marketing experience suggests that a similar syndrome may occur in patients with other types of malignancy.
Croatian: Iskustvo nakon stavljanja lijeka u promet ukazuje na to da se sličan sindrom može javiti u bolesnika s drukčijim vrstama maligne bolesti.
English: In case of reappearance of hepatotoxicity, TRISENOX must be permanently discontinued.
Croatian: U slučaju ponovne pojave hepatotoksičnosti liječenje TRISENOXOM mora se trajno prekinuti.
English: Concentrate for solution for infusion 10 ampoules
Croatian: Koncentrat za otopinu za infuziju 10 ampula
English: What you need to know before you are given TRISENOX
Croatian: Što morate znati prije nego što primite TRISENOX
English: Duration and frequency of treatment
Croatian: Trajanje i učestalost liječenja
English: TRISENOX must be diluted before administration.
Croatian: TRISENOX se mora razrijediti prije primjene.
English: Haematologic complete remission (HCR)
Croatian: potpuna hematološka remisija (engl. hematologic complete remission, HCR)
English: For ECG, electrolytes abnormalities and hepatotoxicity see section 4.4.
Croatian: Za EKG, poremećaje elektrolita i hepatotoksičnost vidjeti dio 4.4.
English: The plasma concentration of AsIII declines from peak plasma concentration in a biphasic manner with a mean terminal elimination half-life of 10 to 14 hours.
Croatian: Plazmatske koncentracije AsIII opadaju s vršnih plazmatskih koncentracija na dvofazni način sa srednjim terminalnim poluvremenom eliminacije od 10 do 14 sati.
English: For patients with severe, acute arsenic overdose, dialysis should be considered
Croatian: Za bolesnike s teškim, akutnim predoziranjem arsenom potrebno je uzeti u obzir dijalizu.
English: Almac Pharma Services Limited, Almac House, 20 Seagoe Industrial Estate, Craigavon, BT63 5QD, United Kingdom
Croatian: Almac Pharma Services Limited, Almac House, 20 Seagoe Industrial Estate, Craigavon, BT63 5QD, Ujedinjeno Kraljevstvo
English: APL = acute promyelocytic leukaemia; ATRA = all-trans-retinoic acid
Croatian: APL = akutna promijelocitna leukemija; ATRA = sve-trans-retinoatna kiselina
English: TRISENOX was administered intravenously over 1 to 2 hours until the bone marrow was free of leukaemic cells, up to a maximum of 60 days.
Croatian: TRISENOX je primjenjivan intravenski tijekom 1 do 2 sata sve dok koštana srž nije bila bez leukemičnih stanica, a maksimalno do 60 dana.
English: Consolidation therapy began 6 weeks (range, 3-8) after induction in the single institution study and 4 weeks (range, 3-6) in the multicentre study.
Croatian: Konsolidacijska terapija počela je 6 tjedana (raspon, 3-8) nakon indukcije u monocentričnom ispitivanje i 4 tjedna (raspon, 3-6) nakon indukcije u multicentričnom ispitivanju.
English: Do not use the preparation if foreign particulate matter is present.
Croatian: Nemojte koristiti otopinu ako su u njoj prisutne strane čestice.
English: WBC counts during consolidation were not as high as during induction treatment and were < 10 x 103/μl, except in one patient who had a WBC count of 22 x 103/μl during consolidation.
Croatian: Vrijednosti leukocita tijekom konsolidacije nisu bile tako visoke kao što su bile tijekom indukcijskog liječenja i iznosile su < 10 x 103/μl, osim u jednog bolesnika koji je imao broj leukocita 22 x 103/μl tijekom konsolidacije.
English: Arsenic trioxide has been shown to be embryotoxic and teratogenic in animal studies (see section 5.3).
Croatian: Trudnoća Arsenov trioksid pokazao se embriotoksičnim i teratogenim u ispitivanjima na životinjama (vidjeti dio 5.3).
English: The mean estimated terminal elimination half-lives of the metabolites MMAV and DMAV are 32 hours and
Croatian: Procijenjena srednja vrijednost terminalnog poluvremena eliminacije metabolita MMAV i DMAV su 32 sata odnosno 70 sati.
English: TRISENOX must be administered under the supervision of a physician who is experienced in the management of acute leukaemias, and the special monitoring procedures described in section 4.4 must be followed.
Croatian: TRISENOX se mora primijeniti pod nadzorom liječnika koji je iskusan u liječenju akutnih leukemija te se mora pridržavati posebnih postupaka nadzora opisanih u dijelu 4.4.
English: As soon as signs and symptoms have subsided, treatment with TRISENOX can be resumed at 50 % of the previous dose during the first 7 days.
Croatian: Čim se znakovi i simptomi povuku, liječenje TRISENOXOM može se nastaviti pri 50% prethodne doze tijekom prvih 7 dana.
English: Clearance is not dependent on the weight of the subject or the dose administered over the dose range studied.
Croatian: Klirens ne ovisi o težini ispitanika ili primijenjenoj dozi iz raspona ispitivanih doza.
English: The patient's electrolyte and glycaemia levels, as well as haematologic, hepatic, renal and coagulation parameter tests must be monitored at least twice weekly, and more frequently for clinically unstable patients during the induction phase and at least weekly during the consolidation phase.
Croatian: Moraju se nadzirati bolesnikove razine elektrolita i glikemije kao i hematološki, renalni, jetreni i koagulacijski parametri najmanje dvaput tjedno, a češće za klinički nestabilne bolesnike tijekom faze indukcije te najmanje jednom tjedno tijekom faze konsolidacije.
English: Approximate accumulation ranged from 1.4- to 8-fold following multiple as compared to single dose administration.
Croatian: Približna akumulacija bila je u rasponu od 1,4 do 8 puta veća nakon primjene višestruke doze u usporedbi s pojedinačnom dozom.
English: Arsenic trioxide can cause QT interval prolongation (see section 4.4).
Croatian: Arsenov trioksid može uzrokovati produljenje QT intervala (vidjeti dio 4.4).
English: QT/QTc prolongation is expected during treatment with arsenic trioxide, and torsade de pointes and complete heart block have been reported.
Croatian: Produljenje intervala QT/QTc očekuje se tijekom liječenja arsenovim trioksidom, a prijavljeni su i torsade de pointes te potpuni srčani blok.
English: If this medicinal product is used during pregnancy or if the patient becomes pregnant while taking this product, the patient must be informed of the potential harm to the foetus.
Croatian: Ako se ovaj lijek koristi tijekom trudnoće ili ako bolesnica zatrudni dok je na terapiji TRISENOXOM, mora se obavijestiti bolesnicu o mogućim štetnim učincima lijeka na plod.
English: You must not receive TRISENOX
Croatian: Ne smijete primiti TRISENOX
English: AsIII is the pharmacologically active species of arsenic trioxide.
Croatian: AsIII je farmakološki aktivni oblik arsenova trioksida.
English: Patients who experience a recurrence of toxicity must be removed from treatment.
Croatian: Bolesnici koji iskuse povratne reakcije toksičnosti moraju prekinuti liječenje.
English: 2-Year overall survival (OS)
Croatian: 2-godišnje ukupno preživljenje (engl. overall survival, OS)
English: Peripheral neuropathy, characterised by paraesthesia/dysaesthisia, is a common and well known effect of environmental arsenic.
Croatian: Periferna neuropatija koju karakterizira parestezija/dizestezija čest je i dobro poznati učinak arsena iz okoliša.
English: The Kaplan-Meier median CR duration for the single institution study is 14 months and has not been reached for the multicentre study.
Croatian: Kaplan-Meierov medijan potpune remisije tijekom trajanja u monocentričnom ispitivanju iznosi 14 mjeseci te nije postigao vrijednost iz multicentričnog ispitivanja.
English: No clear trend toward an increase in systemic exposure to AsIII, AsV, MMAV or DMAV was observed with decreasing level of hepatic function as assessed by dose-normalized (per mg dose) AUC.
Croatian: Nije primijećen jasan trend povećanja sistemske izloženosti AsIII, AsV, MMAVili DMAV s opadajućom razinom jetrene funkcije kako se to vidi iz AUC-a normalizirane doze (po mg doze).
English: Hepatotoxicity (grade 3-4)
Croatian: Hepatotoksičnost (3.- 4. stupnja)
English: The mechanism of action of TRISENOX is not completely understood.
Croatian: Mehanizam djelovanja TRISENOXA nije potpuno razjašnjen.
English: Other medicines and TRISENOX
Croatian: Drugi lijekovi i TRISENOX
English: Only 2 relapsed/refractory APL patients discontinued treatment early due to this adverse event and one went on to receive additional TRISENOX on a subsequent protocol.
Croatian: Samo su 2 bolesnika s APL-om koji je bio u fazi relapsa/refraktoran na liječenje prekinula liječenje ranije zbog ovog štetnog događaja, a jedan je primio dodatni TRISENOX tijekom naknadnog protokola.
English: In the total single dose range of 7 to 32 mg (administered as 0.15 mg/kg), systemic exposure (AUC) appears to be linear.
Croatian: U ukupnom rasponu pojedinačne doze od 7 do 32 mg (primijenjena kao 0,15 mg/kg), sistemska izloženost (AUC) čini se linearnom.
English: After dilution in intravenous solutions, TRISENOX is chemically and physically stable for 24 hours at 15-30 °C and 72 hours at refrigerated (2-8 °C) temperatures.
Croatian: Nakon razrjeđivanja u intravenskoj otopini, TRISENOX je kemijski i fizički stabilan 24 sata pri temperaturi od 15-30 °C i 72 sata pri nižim temperaturama (2-8 °C).
English: 32 days
Croatian: 32 dana
English: This is probably due to the confounding of adverse events by the uncontrolled disease process early on in the treatment course and the myriad concomitant medicinal products required to control symptoms and morbidity.
Croatian: To je vjerojatno stoga jer štetni događaji interferiraju s nekontroliranim procesom bolesti u ranoj fazi liječenja te su potrebni brojni istodobno primijenjeni lijekovi za kontrolu simptoma i morbiditeta.
English: TRISENOX is used in adult patients with newly diagnosed low-to-intermediate risk acute promyelocytic leukaemia (APL), and in adult patients, whose disease has not responded to other therapies.
Croatian: TRISENOX se koristi u odraslih bolesnika s novodijagnosticiranom akutnom promijelocitnom leukemijom (APL) niskog do srednjeg rizika te u odraslih bolesnika čija bolest ne reagira na druga liječenja.
English: Hydroxyurea should be continued at a given dose to keep the white blood cell count ≤ 10 x 103/μl and subsequently tapered.
Croatian: Potrebno je nastaviti s primjenom hidroksiureje pri danoj dozi radi održanja broja bijelih krvnih stanica na ≤ 10 x 103/μl i naknadno je postupno sniziti.
English: For QTc greater than 500 msec, corrective measures must be completed and the QTc reassessed with serial ECGs and, if available, a specialist advice could be sought prior to considering using TRISENOX.
Croatian: Za QTc intervale veće od 500 ms treba moraju se dovršiti korektivne mjere te ponovno ispitati QTc serijskim EKG-ovima te se, ako je dostupan, može potražiti savjet specijalista prije razmatranja liječenja TRISENOXOM.
English: Single centre trial N=12
Croatian: Monocentrično ispitivanje N = 12
English: There is no experience on the effect of TRISENOX on the variant APL containing the t(11;17) and t(5;17) chromosomal translocations.
Croatian: Nema iskustva s učinkom TRISENOXA na varijante APL-a s kromosomskim translokacijama t(11;17) i t(5;17).
English: TRISENOX must be diluted with a solution containing glucose or a solution containing sodium chloride.
Croatian: TRISENOX se mora razrijediti otopinom koja sadrži glukozu ili natrijev klorid.
English: The median age in the single centre study was 33 years (age range 9 to 75).
Croatian: Medijan dobi u monocentričnom ispitivanju iznosio je 33 godine (raspon dobi od 9 do 75 godina).
English: For patients who cannot take oral medicinal product, dimercaprol administered at a dose of 3 mg/kg intramuscularly every 4 hours until any immediately life-threatening toxicity has subsided may be considered.
Croatian: Za bolesnike koji ne mogu uzimati oralne lijekove, može se razmotriti primjena dimerkaprola u dozi od 3 mg/kg intramuskularno svaka 4 sata sve dok ne prestane bilo koja po život opasna neposredna toksičnost.
English: TRISENOX is expected to have no or negligible influence on your ability to drive and use machines.
Croatian: Za TRISENOX se očekuje da ne utječe ili zanemarivo utječe na Vašu sposobnost vožnje i rada sa strojevima.
English: TRISENOX must be given under the supervision of a physician experienced in the treatment of acute leukaemias.
Croatian: TRISENOX se mora dati pod nadzorom liječnika koji je iskusan u liječenju akutnih leukemija.
English: If clinically justified/required, concomitant diuretic therapy is also recommended.
Croatian: Ako je klinički opravdano/potrebno, također se preporučuje istodobna terapija diureticima.
English: Treatment should be continued for 4 weeks on and 4 weeks off, for a total of 4 cycles.
Croatian: Liječenje je potrebno nastaviti tijekom 4 tjedna nakon čega slijedi 4 tjedna pauze, što se ponavlja kroz ukupno 4 ciklusa.
English: During therapy with TRISENOX, potassium concentrations must be kept above 4 mEq/l and magnesium concentrations must be kept above 1.8 mg/dl.
Croatian: moraju se držati koncentracije kalija iznad 4 mEq/l, a magnezija iznad 1,8 mg/dl.
English: If your disease responds to TRISENOX, you will be given a second treatment cycle of 25 doses given 5 days per week (followed by 2 days interruption) for 5 weeks.
Croatian: Ako Vaša bolest reagira na liječenje TRISENOXOM, započet ćete drugi ciklus liječenja od 25 doza koje se daju 5 dana u tjednu (nakon čega slijedi 2 dana pauze), tijekom 5 tjedana.
English: Other antileukaemic medicinal products The influence of TRISENOX on the efficacy of other antileukaemic medicinal products is unknown.
Croatian: Drugi lijekovi protiv leukemije Utjecaj TRISENOXA na djelotvornost drugih lijekova protiv leukemije nije poznat.